Patents by Inventor Carlos Puig Duran

Carlos Puig Duran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOUNDS ACTIVATING THE NRF2 PATHWAY
    Publication number: 20200255478
    Abstract: The invention relates to peptidic compounds, which peptidic compounds are compounds of formula (I)?, or a pharmaceutically acceptable salt, or solvate, or N-oxide, or stereoisomer thereof: wherein R1; R2; s; t; u; Aa78 and G1 are as defined herein. The peptidic compounds are useful in activating the Nrf2 pathway.
    Type: Application
    Filed: August 8, 2018
    Publication date: August 13, 2020
    Inventors: Carlos PUIG DURAN, Fernando ALBERICIO PALOMERA, Miriam GONGORA BENITEZ, Marta PARADIS BAS, Laia MIRET CASALS, Ivan RAMOS TOMILLERO, Stephen FIACCO, Andrew DAVIS, Stefan GESCHWINDNER, Omar BRUN CUBERO, Carlos HERAS PANIAGUA, Nuria TRALLERO CANELA
  • Combinations comprising MABA compounds and corticosteroids
    Patent number: 10456390
    Abstract: A combination which comprises (a) corticosteroid and (b) a dual muscarinic antagonist-?2 adrenergic agonist compound, or any pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: July 24, 2014
    Date of Patent: October 29, 2019
    Assignee: Almirall, S.A.
    Inventors: Monica Aparici Virgili, Marta Calbet Murtro, Montserrat Miralpeix Guell, Amadeu Gavalda Monedero, Carlos Puig Duran
  • Cyclohexylamine derivatives having ?2 adrenergic agonist and M3 muscarinic antagonist activities
    Patent number: 10300072
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: May 28, 2019
    Assignee: Almirall, S.A.
    Inventors: Jose Aiguade Bosch, Silvia Gual Roig, Maria Prat Quinones, Carlos Puig Duran
  • Bicyclic derivatives having ?2 adrenergic agonist and M3 muscarinic antagonist activities
    Patent number: 10005771
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: June 26, 2018
    Assignee: Almirall, S.A.
    Inventors: Carlos Puig Duran, Jose Aiguade Bosch, Silvia Gual Roig, Maria Prat Quiñones
  • CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
    Publication number: 20180015097
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Application
    Filed: August 4, 2017
    Publication date: January 18, 2018
    Inventors: Jose AIGUADE BOSCH, Silvia Gual Roig, Maria Prat Quinones, Carlos Puig Duran
  • NEW BICYCLIC DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
    Publication number: 20170275277
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Application
    Filed: September 24, 2015
    Publication date: September 28, 2017
    Inventors: Carlos PUIG DURAN, Jose AIGUADE BOSCH, Silvia GUAL ROIG, Maria PRAT QUIÑONES
  • Cyclohexylamine derivatives having ?2 adrenergic agonist and M3 muscarinic antagonist activities
    Patent number: 9757383
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: September 12, 2017
    Assignee: Almirall, S.A.
    Inventors: Jose Aiguade Bosch, Silvia Gual Roig, Maria Prat Quinones, Carlos Puig Duran
  • Cyclohexylamine derivatives having ?2 adrenergic antagonist and M3 muscarinic antagonist activities
    Patent number: 9643961
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: May 9, 2017
    Assignee: Almirall, S.A.
    Inventors: Maria Prat Quinones, Silvia Fonquerna Pou, Carlos Puig Duran, Wenceslao Lumeras Amador, Jose Aiguade Bosch, Juan Francisco Caturla Javaloyes
  • Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and ?2 adrenergic receptor agonist activities
    Patent number: 9579316
    Abstract: The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives and (ii) a dicarboxylic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof.
    Type: Grant
    Filed: July 24, 2014
    Date of Patent: February 28, 2017
    Assignee: Almirall, S.A.
    Inventors: Montserrat Julia Jane, Francesc Carrera Carrera, Maria Prat Quiñones, Carlos Puig Duran, Francesca Pajuelo Lorenzo, Juan Antonio Perez Andres
  • Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both ?2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities
    Patent number: 9562039
    Abstract: The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives and (ii) a hydroxycarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: February 7, 2017
    Assignee: Almirall, S.A.
    Inventors: Montserrat Julia Jane, Francesc Carrera Carrera, Maria Prat Quiñones, Carlos Puig Duran, Francesca Pajuelo Lorenzo, Juan Antonio Perez Andres
  • Cyclohexylamine derivatives having ?2 adrenergic agonist and M3 muscarinic antagonist activities
    Patent number: 9549934
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: January 24, 2017
    Assignee: Almirall, S.A.
    Inventors: Jose Aiguade Bosch, Silvia Gual Roig, Maria Prat Quinones, Carlos Puig Duran
  • Cyclohexyl and quinuclidinyl carbamate derivatives having ?2 adrenergic agonist and M3 muscarinic antagonist activity
    Patent number: 9518050
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: December 13, 2016
    Assignee: Almirall, S.A.
    Inventors: Laia Sole Feu, Ines Carranco Moruno, Jose Aiguade Bosch, Carlos Puig Duran, Silvia Fonquerna Pou
  • NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
    Publication number: 20160264557
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Application
    Filed: March 14, 2016
    Publication date: September 15, 2016
    Inventors: Maria PRAT QUINONES, Silvia FONQUERNA POU, Carlos PUIG DURAN, Wenceslao LUMERAS AMADOR, Jose AIGUADE BOSCH, Juan Francisco CATURLA JAVALOYES
  • NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
    Publication number: 20160200718
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Application
    Filed: December 2, 2015
    Publication date: July 14, 2016
    Inventors: Jose AIGUADE BOSCH, Silvia GUAL ROIG, Maria PRAT QUINONES, Carlos PUIG DURAN
  • COMBINATIONS COMPRISING MABA COMPOUNDS AND CORTICOSTEROIDS
    Publication number: 20160175295
    Abstract: A combination which comprises (a) corticosteroid and (b) a dual muscarinic antagonist-?2 adrenergic agonist compound, or any pharmaceutically acceptable salt or solvate thereof.
    Type: Application
    Filed: July 24, 2014
    Publication date: June 23, 2016
    Inventors: Monica APARICI VIRGILI, Marta CALBET MURTRO, Montserrat MIRALPEIX GUELL, Amadeu GAVALDA MONEDERO, Carlos PUIG DURAN
  • SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITIES
    Publication number: 20160166566
    Abstract: The present invention is directed to crystalline addition salts of (ii) 8-hydroxyquinolin-2(1H)-one derivatives and (ii) a dicarboxylic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof.
    Type: Application
    Filed: July 24, 2014
    Publication date: June 16, 2016
    Inventors: Montserrat JULIA JANE, Francesc CARRERA CARRERA, Maria PRAT QUIÑONES, Carlos PUIG DURAN, Francesca PAJUELO LORENZO, Juan Antonio PEREZ ANDRES
  • NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
    Publication number: 20160143915
    Abstract: The present invention relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Application
    Filed: December 2, 2015
    Publication date: May 26, 2016
    Inventors: Jose AIGUADE BOSCH, Silvia GUAL ROIG, Maria PRAT QUINONES, Carlos PUIG DURAN
  • Cyclohexylamine derivatives having ?2 adrenergic agonist and M3 muscarinic antagonist activities
    Patent number: 9315463
    Abstract: The present disclosure relates to novel compounds having ?2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
    Type: Grant
    Filed: May 13, 2011
    Date of Patent: April 19, 2016
    Assignee: Almirall, S.A.
    Inventors: Maria Prat Quinones, Silvia Fonquerna Pou, Carlos Puig Duran, Wenceslao Lumeras Amador, Jose Aiguade Bosch, Juan Francisco Caturla Jovaloyes
  • COMBINATIONS COMPRISING MABA COMPOUNDS AND CORTICOSTEROIDS
    Publication number: 20160015704
    Abstract: A combination which comprises (a) corticosteroid and (b) a dual muscarinic antagonist-?2 adrenergic agonist compound, or any pharmaceutically acceptable salt or solvate thereof.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 21, 2016
    Inventors: Monica APARICI VIRGILI, Marta CALBET MURTRO, Montserrat MIRALPEIX GUELL, Amadeu GAVALDA MONEDERO, Carlos PUIG DURAN
  • SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH ?2 ADRENERGIC RECEPTOR AGONIST AND M3 MUSCARINIC RECEPTOR ANTAGONIST ACTIVITIES
    Publication number: 20160009698
    Abstract: The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives and (ii) a hydroxycarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 14, 2016
    Inventors: Montserrat JULIA JANE, Francesc CARRERA CARRERA, Maria PRAT QUIÑONES, Carlos PUIG DURAN, Francesca PAJUELO LORENZO, Juan Antonio PEREZ ANDRES